Ali Bazarbachi, MD, PhD is a Professor of Medicine (Hematology and Oncology), and founding director of the bone marrow transplantation program at the American University of Beirut-Medical Center. He received his MD and PhD degrees from the University of Paris. His translational research focuses on targeted therapies for hematological malignancies as well as post-transplant pharmacological interventions. He has co-authored more than 400 articles in leading scientific journals including The New England Journal of Medicine, Science, Journal of Experimental Medicine, The Lancet Oncology, Journal of Clinical Oncology, Blood, and Nature Communication. He is the Chairman of the EBMT Lymphoma Working Party, Chairman of the NCCN Lymphoma Group for MENA, and Associate Editor of “Bone Marrow Transplantation”. He garnered multiple prestigious national and international awards including the King Hussein Lifetime Achievement Award, and the Lebanese National Medal of Merit. He was recently elected as member of the French National Academy of Medicine.